Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia
RecruitingNCT04871048Phase: NAStarted 2023-02-15
Summary
Cannabis use disorder is a frequent comorbidity of schizophrenia, associated with increased symptoms and less adherence to therapy. Validated care has limited effectiveness in this population and deve
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
60 Years
Locations
CH Le Vinatier Service universitaire d'addictologie de LyonBron, France
Centre Hospitalier Universitaire Service d'Addictologie et PClermont-Ferrand, France
CHU de Clermont-Ferrand Service de PsychiatrieClermont-Ferrand, France
Service Hospitalo-Universitaire d'Addictologie CHU de DijonDijon, France
CHU Pôle de Psychiatrie Neurologie et RééducationLa Tronche, France
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT04871048